These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 28829118)

  • 1. Bioactive Natural Products Prioritization Using Massive Multi-informational Molecular Networks.
    Olivon F; Allard PM; Koval A; Righi D; Genta-Jouve G; Neyts J; Apel C; Pannecouque C; Nothias LF; Cachet X; Marcourt L; Roussi F; Katanaev VL; Touboul D; Wolfender JL; Litaudon M
    ACS Chem Biol; 2017 Oct; 12(10):2644-2651. PubMed ID: 28829118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High impact technologies for natural products screening.
    Koehn FE
    Prog Drug Res; 2008; 65():175, 177-210. PubMed ID: 18084916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting bioactive compounds in natural extracts - Development of a comprehensive workflow combining chemical and biological data.
    Ory L; Nazih EH; Daoud S; Mocquard J; Bourjot M; Margueritte L; Delsuc MA; Bard JM; Pouchus YF; Bertrand S; Roullier C
    Anal Chim Acta; 2019 Sep; 1070():29-42. PubMed ID: 31103165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative omics-based approaches for prioritisation and targeted isolation of natural products - new strategies for drug discovery.
    Wolfender JL; Litaudon M; Touboul D; Queiroz EF
    Nat Prod Rep; 2019 Jun; 36(6):855-868. PubMed ID: 31073562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of high-content screening and untargeted metabolomics for comprehensive functional annotation of natural product libraries.
    Kurita KL; Glassey E; Linington RG
    Proc Natl Acad Sci U S A; 2015 Sep; 112(39):11999-2004. PubMed ID: 26371303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivity-Based Molecular Networking for the Discovery of Drug Leads in Natural Product Bioassay-Guided Fractionation.
    Nothias LF; Nothias-Esposito M; da Silva R; Wang M; Protsyuk I; Zhang Z; Sarvepalli A; Leyssen P; Touboul D; Costa J; Paolini J; Alexandrov T; Litaudon M; Dorrestein PC
    J Nat Prod; 2018 Apr; 81(4):758-767. PubMed ID: 29498278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemical study on bioactive natural products of novel structural types].
    Yu SS; Feng XZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):347-50. PubMed ID: 15379253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid MS/NMR methods on the prioritization of natural products: Applications in drug discovery.
    Gomes NGM; Pereira DM; Valentão P; Andrade PB
    J Pharm Biomed Anal; 2018 Jan; 147():234-249. PubMed ID: 28826951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations of the chemical biology of microbial natural products provide an effective drug discovery strategy.
    Choi H; Oh DC
    Arch Pharm Res; 2015 Sep; 38(9):1591-605. PubMed ID: 26231248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target identification of natural products and bioactive compounds using affinity-based probes.
    Pan S; Zhang H; Wang C; Yao SC; Yao SQ
    Nat Prod Rep; 2016 May; 33(5):612-20. PubMed ID: 26580476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural products-prompted chemical biology: phenotypic screening and a new platform for target identification.
    Kakeya H
    Nat Prod Rep; 2016 May; 33(5):648-54. PubMed ID: 26883503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical and biological integrity in natural products screening.
    Harrigan GG; Goetz GH
    Comb Chem High Throughput Screen; 2005 Sep; 8(6):529-34. PubMed ID: 16178812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAPROC-13: a database for the dereplication of natural product mixtures in bioassay-guided protocols.
    López-Pérez JL; Therón R; del Olmo E; Díaz D
    Bioinformatics; 2007 Dec; 23(23):3256-7. PubMed ID: 17956876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining Activity Profiling with Advanced Annotation to Accelerate the Discovery of Natural Products Targeting Oncogenic Signaling in Melanoma.
    Hell T; Rutz A; Dürr L; Dobrzyński M; Reinhardt JK; Lehner T; Keller M; John A; Gupta M; Pertz O; Hamburger M; Wolfender JL; Garo E
    J Nat Prod; 2022 Jun; 85(6):1540-1554. PubMed ID: 35640148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural products from cyanobacteria: Exploiting a new source for drug discovery.
    Sielaff H; Christiansen G; Schwecke T
    IDrugs; 2006 Feb; 9(2):119-27. PubMed ID: 16523402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to diversify natural products for drug discovery.
    Li G; Lou HX
    Med Res Rev; 2018 Jul; 38(4):1255-1294. PubMed ID: 29064108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counting on natural products for drug design.
    Rodrigues T; Reker D; Schneider P; Schneider G
    Nat Chem; 2016 Jun; 8(6):531-41. PubMed ID: 27219696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for target identification of antimicrobial natural products.
    Farha MA; Brown ED
    Nat Prod Rep; 2016 May; 33(5):668-80. PubMed ID: 26806527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemically engineered extracts: source of bioactive compounds.
    Ramallo IA; Salazar MO; Mendez L; Furlan RL
    Acc Chem Res; 2011 Apr; 44(4):241-50. PubMed ID: 21355557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-content screening of natural products reveals novel nuclear export inhibitors.
    Cautain B; de Pedro N; Murillo Garzón V; Muñoz de Escalona M; González Menéndez V; Tormo JR; Martin J; El Aouad N; Reyes F; Asensio F; Genilloud O; Vicente F; Link W
    J Biomol Screen; 2014 Jan; 19(1):57-65. PubMed ID: 24045581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.